Semaglutide vs Tirzepatide for Constipation: Which Is Worse?
Constipation is the silent struggle of GLP-1 treatment. Here is how semaglutide and tirzepatide compare, and what actually works to fix it.
Medical Disclaimer: This comparison is for informational purposes only. Consult your healthcare provider about managing side effects.
While nausea gets all the attention, constipation is one of the most persistent and bothersome GLP-1 side effects. Unlike nausea, which often improves with time, constipation can continue throughout treatment without active management.
The Clinical Data
| Metric | Semaglutide | Tirzepatide |
|---|---|---|
| Constipation rate | 24% (STEP 1) | 12-17% (SURMOUNT-1) |
| Severe constipation | ~2% | ~1% |
| Diarrhea rate (alternating) | 30% | 17-21% |
| Onset | Weeks 1-4 | Weeks 1-4 |
Why GLP-1 Medications Cause Constipation
Three mechanisms combine to create the problem:
- Slowed GI motility: GLP-1 medications slow the entire digestive tract, not just the stomach
- Reduced food volume: Less food means less bulk moving through the intestines
- Reduced fiber intake: When you eat less overall, fiber intake often drops below the 25-30g daily minimum
A Tiered Approach to Management
Tier 1 (Start here): Increase water to 80+ oz daily. Add fiber-rich foods (berries, vegetables, whole grains). Walk daily for at least 20 minutes.
Tier 2 (If Tier 1 is not enough): Add a fiber supplement (psyllium husk, 5-10g daily). Consider magnesium citrate (200-400mg at bedtime). Probiotic foods or supplements.
Tier 3 (Persistent cases): Osmotic laxative (MiraLAX, 17g daily as needed). Stool softener (docusate 100mg daily). Discuss with provider if lasting more than 2 weeks.
Tier 4 (Severe): Prescription options like linaclotide or lubiprostone. Dose reduction of GLP-1 medication. Referral to gastroenterology if needed.
The Bottom Line
Our Assessment
Tirzepatide has a slight advantage with lower constipation rates in clinical trials. However, constipation on either medication is highly manageable with proactive fiber, hydration, and lifestyle strategies. Do not choose between medications based on constipation alone — it is fixable regardless of which you take.
Frequently Asked Questions
Which GLP-1 causes more constipation — semaglutide or tirzepatide?
Both cause constipation at similar rates. Semaglutide (STEP 1) reported 24% constipation rates, while tirzepatide (SURMOUNT-1) reported 12-17% depending on dose. Tirzepatide may have slightly lower constipation rates, but both can cause significant GI slowing.
Why do GLP-1 medications cause constipation?
GLP-1 receptor agonists slow gastric emptying and overall gut motility. Combined with reduced food and fiber intake from appetite suppression, stool moves more slowly through the intestines and becomes harder and drier.
What is the best remedy for GLP-1 constipation?
A combination approach works best: increase water intake to 80+ oz daily, add a fiber supplement (psyllium husk, 5-10g daily), eat high-fiber foods when possible, stay physically active, and use an osmotic laxative (MiraLAX) if needed. Stool softeners (docusate) can also help.
When should I see a doctor about constipation on GLP-1 medication?
Seek medical attention if you have not had a bowel movement in 4+ days, experience severe abdominal pain, notice blood in your stool, or have vomiting with constipation. These could indicate a bowel obstruction, which is rare but serious.
Side Effect Support with Trimi
Our clinicians help you manage every side effect. Compounded semaglutide from $99/mo or tirzepatide from $125/mo.
Get Started TodayMore on Micro-Comparisons
Sources & References
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. NEJM 2021;384:989-1002.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205-216.
- Lincoff AM et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. NEJM 2023;389:2221-2232.
- FDA Prescribing Information for Wegovy (semaglutide) and Zepbound (tirzepatide).